HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HD Biosciences (China) Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10877
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others. It offers services including hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, technology around target validation, plate-based pharmacology, and other research and development services. HDB offers services in the therapeutic areas of oncology, metabolic diseases, CNS diseases, inflammation and immunology, liver diseases, and infectious diseases. The organization also provides custom peptides synthesis services, kinase assay, bio analysis, ion channels, transporters and high-throughput screening format using plate based platforms. It has operations in China and the US. HDB is headquartered in Pudong, China.

HD Biosciences (China) Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
HD Biosciences Enters into Co-development Agreement with ABBIOSCI 10
HD Biosciences Enters into Co-Development Agreement with MIIR and Joan C. Edwards School of Medicine 11
Acquisition 12
WuXi AppTec Acquires HD Biosciences 12
HD Biosciences (China) Co Ltd – Key Competitors 13
HD Biosciences (China) Co Ltd – Key Employees 14
HD Biosciences (China) Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HD Biosciences Enters into Co-development Agreement with ABBIOSCI 10
HD Biosciences Enters into Co-Development Agreement with MIIR and Joan C. Edwards School of Medicine 11
WuXi AppTec Acquires HD Biosciences 12
HD Biosciences (China) Co Ltd, Key Competitors 13
HD Biosciences (China) Co Ltd, Key Employees 14
HD Biosciences (China) Co Ltd, Other Locations 15

List of Figures
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HD Biosciences (China) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PaR Systems LLC:企業の戦略的SWOT分析
    PaR Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Grupo Mexico SAB de CV:戦略・SWOT・企業財務分析
    Grupo Mexico SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Mexico SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Givaudan SA:企業の戦略・SWOT・財務情報
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • RWE AG:企業の戦略・SWOT・財務情報
    RWE AG - Strategy, SWOT and Corporate Finance Report Summary RWE AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Royal Dutch Shell plc:企業のM&A・事業提携・投資動向
    Royal Dutch Shell plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Dutch Shell plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ACTIVE Network, LLC:企業のM&A・事業提携・投資動向
    ACTIVE Network, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ACTIVE Network, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Imobiliaria Construtora Grao-Para SA:企業の戦略・SWOT・財務情報
    Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report Summary Imobiliaria Construtora Grao-Para SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Odebrecht S.A.:企業の戦略・SWOT・財務情報
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sumitomo Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Vivergo Fuels Ltd:企業の戦略的SWOT分析
    Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Airgas, Inc.:企業のM&A・事業提携・投資動向
    Airgas, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airgas, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Tobira Therapeutics Inc (TBRA)-製薬・医療分野:企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Seafarms Group Ltd (SFG):企業の財務・戦略的SWOT分析
    Seafarms Group Ltd (SFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bharti Airtel Limited:企業の戦略・SWOT・財務分析
    Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report Summary Bharti Airtel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • McGill University-製薬・医療分野:企業M&A・提携分析
    Summary McGill University (McGill) is a research based educational institute. The university offers undergraduate, graduate and post-graduate courses. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, l …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Petrol dd Ljubljana (PETG):企業の財務・戦略的SWOT分析
    Petrol dd Ljubljana (PETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆